Last Updated : July 31, 2019
The Pharmaceutical Advisory Committee Formulary Working Group for Health Technology Assessments (FWG-HTA) includes representatives from the federal, provincial, and territorial health ministries, and related health organizations. The FWG-HTA provides advice on CADTH optimal use projects. Working group members also facilitate effective jurisdictional sharing of optimal use information.
| Chair | |
|---|---|
| British Columbia | Clifford Lo |
| Members | |
| Alberta | Sandra Rees |
| Saskatchewan | Michelle Pashovitz/Donna Herbert |
| Non-Insured Health Benefits | Karen Fortin |
| Manitoba | Amy Yu |
| New Brunswick | Tina LeClerc |
| Newfoundland and Labrador | Colleen Ryan |
| Nova Scotia | Nicole Cluett |
| Ontario | Laureen Rance |
| Prince Edward Island | Marsha Cusack |
| Yukon Territory | Shauna Demers |
| Correctional Service Canada | Alka Bhalla |
| Canadian Armed Forces | Michelle Sullivan |
| Veterans Affairs Canada | Anne Bastarache |
| Pan-Canadian Pharmaceutical Alliance | Jane Lui |
| Observers | |
| Health Canada | Barry Jones |
| PMPRB | Dianne Breau |
| Canadian Institute for Health Information | Cathy MacMillan |
| INESSS | Marie Hotte |
| Canadian Blood Services | Sylvain Grenier |
Last Updated : July 31, 2019